title: Highly attenuated poxvirus vectors.
authors: Virogenetics Corporation, Troy, NY 12180.
authors: J
authors: J
authors: Tartaglia
authors: W I
authors: WI
authors: Cox
authors: J
authors: J
authors: Taylor
authors: M
authors: M
authors: Perkus
authors: M
authors: M
authors: Riviere
authors: B
authors: B
authors: Meignier
authors: E
authors: E
authors: Paoletti
mesh_terms: D016915:AIDS Vaccines; D000818:Animals; D005822:Genetic Vectors; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D016867:Immunocompromised Host; D051379:Mice; D008807:Mice, Inbred BALB C; D011212:Poxviridae / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D012900:Smallpox Vaccine; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000633:toxicity; D014614:Vaccines, Synthetic / Q000633:toxicity; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D014765:Viral Vaccines / Q000276:immunology / Q000633:toxicity
chemical_list: D016915:AIDS Vaccines; C078788:ALVAC vaccine; C078786:DryVax vaccine; C078787:NYVAC vaccine; D011994:Recombinant Proteins; D012900:Smallpox Vaccine; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines